About James Wells
Form D filings for EpiBiologics from 2023 to 2024 list James Wells as director.
James Wells first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name James Wells in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Wells works with at each company, as listed on that company's latest Form D.
EpiBiologics, Inc. · Form D/A, Apr 25, 2024
JC
Jason Coloma
Director
AK
Ann Lee-Karlon
CEO and director
SB
Samuel Bjork
Director
Alexandra Cantley
Director
MM
Mitchell Mutz
Executive officer and director
SM
Seiji Miyahara
Director